Private Market View

Symbiotic

Dubai, United Arab Emirates · Founded 2023 · Privately Held (backing)

Last price · $/share
Implied valuation
$175.0M
Total raised
$34.8M
Last round

Key facts

  • Symbiotic’s last known valuation is $175.0M (Apr 2025).
  • It has raised $34.8M; the latest was Early Stage VC ($29.0M) in Apr 2025.
  • Notable investors include Coinbase Ventures, Pantera Capital, Cyber.Fund, Sandeep Nailwal, Ambush Capital18 tracked in total.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·The complete investor list — 18 names
  • ·Watchlist + deal alerts for Symbiotic
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for Symbiotic are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

About Symbiotic

Developer of a shared security protocol designed to improve the decentralized network. The company's software offers smart contracts to enable secure, decentralized on-chain conversions based on the available staked liquidity of traded assets, allowing users to trade tokens online without using an intermediary.

Sector
Financial Services
HQ
Dubai, United Arab Emirates
Founded
2023
Employees
19
Ownership
Privately Held (backing)
PA Mark — not yet priced

Symbiotic doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Symbiotic shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Symbiotic in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.